Children’s Hospital of Philadelphia (CHOP) is delighted to share the initial outcomes of an experimental gene therapy intervention for a patient with hereditary hearing loss in the U.S., marking a significant breakthrough in the global treatment of hearing loss caused by various genetic mutations.